Left ventricular assist as a viable alternative for cardiac transplantation

Critical Care Nursing Quarterly

Volumn 20, Issue 4, 1998, Pages 64-79

  Chillcott, Suzanne R ^a   Atkins, Patricia J ^a   Adamson, Robert M ^a  

^a SHARP MEMORIAL HOSPITAL   (United States)

Author keywords

Cardiac transplantation; End stage cardiomyopathy; Ethical considerations; Heart assist systems; HeartMate; Left ventricular assist system; Patient outcomes

Indexed keywords

ASSISTED CIRCULATION; EMERGENCY TREATMENT; HEALTH CARE COST; HEART FAILURE; HEART TRANSPLANTATION; HOME CARE; HUMAN; IMPLANTATION; INTRAOPERATIVE PERIOD; MEDICAL ETHICS; NURSING EDUCATION; PATIENT SELECTION; POSTOPERATIVE CARE; REVIEW;

EID: 0031964219     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-199802000-00008     Document Type: Review

References (31)

1. Organ Procurement and Transplantation Network/SR 1996 Annual Report. United Network for Organ Sharing (UNOS) Scientific Registry data as of April 15, 1997. Richmond, VA: UNOS.
2. Vaca KJ, Lohmann DP, Moroney DA. Current status and future trends of mechanical circulatory support. Crit Care Nurs Clin NAm. 1995;7:249-258.
3. Frazier OH. First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation. 1994;89:2908-2914.
4. Adamson RM, Dembitsky WP, Jaski BE, et al. Left ventricular assist device support of medically unresponsive pulmonary hypertension. ASAIO J. In press.
5. Frazier OH, Macris MP, Myers TJ, et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994;57:1416-1422.
6. McCarthy PM, Savage RM, Fraser CD, et al. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device. J Thorac Cardiovasc Surg. 1995;109:409-418.
7. Burnett CM, Duncan M, Frazier OH, Sweeney MS, Vea JD, Radovancervic B. Improved multiorgan function after prolonged univentricular support. Ann Thorac Surg. 1993;55:65-71.
8. Burton NA, Lafrak EA, Macmanus Q, et al. A reliable bridge to cardiac transplantation: the TCI left ventricular assist device. Ann Thorac Surg. 1993;55:1425-1431.
9. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222:327-336.
10. Fischer SA, Trenholme GM, Costanzo MR, Piccione W. LVAD-related bloodstream infection: incidence, behavior and prognosis. ASAIO J. 1997;43:37.
11. Frazier OH. Chronic left ventricular support with a vented electric assist device. Ann Thorac Surg. 1993;55:273-275.
12. Oz MC, Goldstein DJ, Pepino P, et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 1995;92[supplI]:II-169-II-173.
13. Mueller J, Semrau S, Spiegelsberger S, et al. Factors influencing the possibility of weaning from mechanical cardiac support systems in patients with end-stage idiopathic dilated cardiomyopathy. ASAIO J. 1997;43:43.
14. Farrar DJ, Hill JD. A new skeletal muscle linear-pull energy convertor as a power source for prosthetic support devices. J Heart Lung Transplant. 1992;11:S341-S350.
15. Farrar DJ, Reichenbach SH, Hill JD. Mechanical advantage of skeletal muscle as a cardiac assist power source. ASAIO J. 1995;41:M481-M484.
16. Parnis SM, Conger J, Fuqua JM, et al. Progress in the development of a transcutaneous axial flow blood pump ventricular assist system. ASAIO J. 1997;43:52.
17. Yamazaki K, Litwak P, Dormos RL. A totally implantable centrifugal blood pump for long-term circulatory support. ASAIO J. 1997;43:51.
18. Rose EA, Levin HR, Oz MC, et al. Artificial circulatory support with textured interior surfaces: a counterintuitive approach to minimizing thromboembolism. Circulation. 1994;90[part 2]:II87-II91.
19. Slater JP, Rose EA, Levin HR. Low thromboembolic risk without anticoagulation using advanced design left ventricular assist devices. Ann Thorac Surg. 1996;62:1321-1328.
20. Oz MC, Goldstein DJ, Rose EA. Preperitoneal placement of ventricular assist devices: an illustrated step-wise approach. J Cardiovasc Surg. 1995;10:288-294.
21. McCarthy PM, Wang N, Vargo R. Preperitoneal insertion of the HeartMate 1000 IP implantable left ventricular assist device. Ann Thorac Surg. 1994;57:634-638.
22. El-Amir NG, Gardocki M, Levin HR, et al. Gastrointestinal consequences of left ventricular assist device placement. ASAIO J. 1996;42:150-153.
23. McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantable LVAS infections: implications for permanent use of the device. Ann Thorac Surg. 1996;61:359-365.
24. Moroney DA, Vaca KJ. Infectious complications associated with ventricular assist devices. Am J Crit Care. 1995;4:204-209.
25. Branch KR, Dembitsky WP, Peterson KL, et al. Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support. J Heart Lung Transplant. 1994;13:641-651.
26. Myers TJ, Dasse KA, Macris MP, Poirier VL, Cloy MJ, Frazier OH. Use of a left ventricular assist device in an outpatient setting. ASAIO J. 1994;40:M471-M475.
27. Dew MA, Kormos RL, Roth LH, et al. Life quality in the era of bridging to cardiac transplantation: bridge patients in an outpatient setting. ASAIO J. 1993;39:145-152.
28. Gardner JR. Billing Medicare for investigational devices: what's OK, what's not. Healthcare Financial Management. 1997;March: 50-54.
29. Cloy MJ, Myers TJ, Stutts LA, Macris MP, Frazier OH. Hospital charges for conventional therapy versus left ventricular assist system therapy in heart transplant patients. ASAIO Journal. 1995;41:M535-M539.
30. Macris MP. Permanent mechanical replacement of the left ventricle. Cardiol Clin. 1995;13:111-120.
31. Catanese KA, Goldstein DJ, Williams DL, et al. Outpatient left ventricular assist device support: a destination rather than a bridge. Ann Thorac Surg. 1996;62:646-653.